June 26, 2015 : Episode 1

Video

Panitumumab in CRC, Ramucirumab in HCC, 13th ICML, and More

Related Videos
Marwan G. Fakih, MD
Kanwal PS Raghav, MBBS, MD
Vikas S. Ostwal, MD
Michael Foote, MD, medical oncologist, assistant attending physician, Memorial Sloan Kettering Cancer Center
Dr André on Nivolumab Plus Ipilimumab in MSI-H/dMMR mCRC
Dr Shreenivas on the Association Between MUC1 and CLDN18 in GI Cancers
Dr Strosberg on Cabozantinib vs Placebo in Patients With Advanced GI NETs
Aasma Shaukat, MD, MPH, discusses the sensitivity of the PREEMPT CRC blood-based assay in detecting colorectal cancer for patients at average risk.
Kanwal P.S. Raghav, MD, MBBS, of MD Anderson Cancer Center